Beyeonics

Surgical Visualization Technologies

Health Tech & Life Sciences
Private
Follow

Company Overview

Snapshot

Founded in February 2018 by Rani Ben-Yishai, Beyeonics operates with 51–200 employees. The company has raised a total of $47.5M across two funding rounds from seven investors. In October 2021, Beyeonics secured a B Round of funding, with ALIVE Israel Healthtech Fund participating as a lead investor.

Business overview

Beyeonics is a medical technology company focused on empowering surgeons through advanced visualization technologies. The company develops open-platform technology that integrates digital surgical platforms in operating rooms using augmented reality, tracking, and image processing/AI. Beyeonics Vision specifically develops Beyeonics One, an ophthalmic exoscope for advanced visualization in eye surgery, while Beyeonics Surgical focuses on neurosurgery and orthopedic surgical platforms, including virtual and augmented reality-based navigation. The company serves the medical and healthcare industries, operating within the Health Tech & Life Sciences sector, with a focus on digital healthcare and medical decision support.

Strategic signal

In October 2021, Beyeonics completed a significant B Round of funding, with ALIVE Israel Healthtech Fund leading the investment. This capital infusion signals strong investor confidence in Beyeonics' innovative surgical visualization technologies and its potential to advance surgical capabilities across multiple disciplines, including ophthalmology, neurosurgery, and orthopedics. The funding will likely accelerate product development and market expansion for its augmented reality and AI-driven platforms.

Log in to access full profile

Company Intelligence Q&A

What is Beyeonics One?
Beyeonics One is an ophthalmic exoscope developed by Beyeonics Vision, designed to provide advanced visualization and unconstrained performance for ophthalmic surgeons.
When did Beyeonics raise its B Round of funding?
In October 2021, Beyeonics raised a B Round of funding. ALIVE Israel Healthtech Fund was a lead investor in this round.
What is the primary focus of Beyeonics Surgical?
Beyeonics Surgical focuses on neurosurgery and orthopedic surgical platforms, with pipeline applications that include minimally invasive surgery utilizing virtual and augmented reality-based navigation and data processing.
Who is a co-founder of Beyeonics?
Rani Ben-Yishai is a co-founder and CTO of Beyeonics.
What core technologies does Beyeonics utilize?
Beyeonics integrates digital surgical platforms using augmented reality, tracking, and image processing/AI technologies to provide surgeons with valuable information and decision guidance.
Log in to access full profile